The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway

doi:10.3390/ijms22073782

Chia Nan University of Pharmacy & Science Institutional Repository > 環境永續暨休閒學院 > 室內空氣品質研究服務中心 > 期刊論文 > Item 310902800/34440

jsp.display-item.identifier=請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34440

標題:	The Fibronectin Expression Determines the Distinct Progressions of Malignant Gliomas via Transforming Growth Factor-Beta Pathway
作者:	Chen, Chih-Wei Yang, Cheng-Han Lin, Yuan-Ho Hou, Ya-Chin Cheng, Tain-Junn Chang, Sheng-Tsung Huang, Yu-Hua Chung, Shang-Ting Chio, Chung-Ching Shan, Yan-Shen Cheng, Hung-Chi Chang, Wen-Tsan
貢獻者:	Natl Cheng Kung Univ, Coll Med, Inst Clin Med Chi Mei Fdn Med Ctr, Dept Surg, Div Neurosurg Chia Nan Univ Pharm & Sci, Coll Sustainable Environm, Dept Occupat Safety & Hlth, Inst Ind Safety & Disaster Prevent Natl Cheng Kung Univ, Coll Med, Inst Basic Med Sci Chi Mei Fdn Med Ctr, Dept Neurol & Occupat Med Chi Mei Fdn Med Ctr, Dept Pathol Chi Mei Fdn Med Ctr, Dept Nursing Natl Cheng Kung Univ, Coll Med, Dept Biochem & Mol Biol Natl Cheng Kung Univ, Coll Med, Dept Surg, Div Gen Surg
關鍵字:	glioma glioblastoma multiforme (GBM) tumor recurrence tumor metastasis epithelial-mesenchymal transition (EMT) fibronectin (FN) vimentin (VIM) transforming growth factor-beta (TGF-946 )
日期:	2021
上傳時間:	2023-11-11 11:52:58 (UTC+8)
出版者:	MDPI
摘要:	Due to the increasing incidence of malignant gliomas, particularly glioblastoma multiforme (GBM), a simple and reliable GBM diagnosis is needed to screen early the death-threaten patients. This study aimed to identify a protein that can be used to discriminate GBM from low-grade astrocytoma and elucidate further that it has a functional role during malignant glioma progressions. To identify proteins that display low or no expression in low-grade astrocytoma but elevated levels in GBM, glycoprotein fibronectin (FN) was particularly examined according to the mining of the Human Protein Atlas. Web-based open megadata minings revealed that FN was mainly mutated in the cBio Cancer Genomic Portal but dominantly overexpressed in the ONCOMINE (a cancer microarray database and integrated data-mining platform) in distinct tumor types. Furthermore, numerous different cancer patients with high FN indeed exhibited a poor prognosis in the PrognoScan mining, indicating that FN involves in tumor malignancy. To investigate further the significance of FN expression in glioma progression, tumor specimens from five malignant gliomas with recurrences that received at least two surgeries were enrolled and examined. The immunohistochemical staining showed that FN expression indeed determined the distinct progressions of malignant gliomas. Furthermore, the expression of vimentin (VIM), a mesenchymal protein that is strongly expressed in malignant cancers, was similar to the FN pattern. Moreover, the level of epithelial-mesenchymal transition (EMT) inducer transforming growth factor-beta (TGF-beta) was almost recapitulated with the FN expression. Together, this study identifies a protein FN that can be used to diagnose GBM from low-grade astrocytoma; moreover, its expression functionally determines the malignant glioma progressions via TGF-beta-induced EMT pathway.
關聯:	INT J MOL SCI, v.22, n.7, pp.3782
显示于类别:	[室內空氣品質研究服務中心] 期刊論文

文件中的档案:

档案	描述	大小	格式	浏览次数
ijms22073782.pdf		6382Kb	Adobe PDF	97	检视/开启
index.html		0Kb	HTML	175	检视/开启

在CNU IR中所有的数据项都受到原著作权保护.

TAIR相关文章

数据加载中.....